Table 6.
Antibiotics tested | Gram-negative |
Gram-positive |
|||||
---|---|---|---|---|---|---|---|
Klebsiella |
Pseudomonas |
Enterobacter |
Acinetobacter |
CoNS |
MRSA |
Strept. |
|
R/T (%) | R/T (%) | R/T (%) | R/T (%) | R/T (%) | R/T (%) | R/T (%) | |
Polymyxin | 0/4(0) | 0/8(0) | |||||
Gentamycin | 32/34(94) | 4/4(100) | 3/3(100) | 6/8(75) | 13/14(93) | 7/7(100) | 1/1(100) |
Amikacin | 28/34(82) | 1/2 (50) | 1/3(33) | 6/8(75) | |||
Meropenem | 32/34(94) | 1/1(100) | 3/3(100) | 1/1(100) | |||
Imipenem | 31/34(91) | 4/4(100) | 3/3(100) | 8/8(100) | |||
Ciprofloxacin | 28/34(82) | 4/4(100) | 1/3(33) | 6/8(75) | 13/13(100) | 7/7(100) | 2/2(100) |
Levofloxacin | 16/34(47) | 4/4(100) | 0/3(0) | 6/8(75) | 13/14(93) | 7/7(100) | 2/2(100) |
SXT | 29/34(85) | IR | 3/3(100) | 7/8(88) | 13/14(93) | 7/7(100) | |
Ampicillin-sulbactam | 34/34(100) | IR | 3/3(100) | 8/8(100) | 17/17(100) | 7/7(100) | 2/2(100) |
Amoxiclav | 34/34(100) | IR | 3/3(100) | 8/8(100) | 15/15(100) | 7/7(100) | 1/1(100) |
Pip-tazo | 34/34(100) | 1/2(50) | 3/3(100) | 8/8(100) | |||
Sulperazone | 34/34(100) | 1/1(100) | 3/3(100) | 8/8(100) | |||
Ceftazidime | 34/34(100) | 3/3(100) | 8/8(100) | ||||
Cefotaxime | 34/34(100) | IR | 3/3(100) | 8/8(100) | 14/15(93) | 7/7(100) | 0/1(0) |
Ceftriaxone | 34/34(100) | IR | 3/3(100) | 8/8(100) | 14/14(100) | 7/7(100) | |
Cefuroxime | 34/34(100) | IR | 3/3(100) | IR | 14/14(100) | ||
Cefoperazone | 34/34(100) | IR | 3/3(100) | 8/8(100) | 14/14(100) | 7/7(100) | |
Cefepime | 34/34(100) | 3/3(100) | 3/3(100) | 8/8(100) | 14/14(100) | ||
Cefoxitin | 34/34(100) | 1/2(50) | 3/3(100) | 8/8(100) | 14/14(100) | 7/7(100) | |
Rifampicin | 13/17(76) | 5/6(83) | |||||
Vancomycin | 0/17(0) | 0/7(0) | 1/2(50) | ||||
Chloramphenicol | 13/17(76) | 2/7(29) | |||||
Linezolid | 0/6(0) | 0/3(0) | 2/2(100) | ||||
Clindamycin | 12/17(71) | 2/7(29) | 0/1(0) | ||||
Erythromycin | 15/17(88) | 7/7(100) | 0/1(0) |
R/T: Number of resistant organisms/total; IR: intrinsic resistance; CoNS: coagulase-negative staphylococci; MRSA: methicillin-resistant Staphylococcus aureus; strept: streptococci; amociclav: amoxicillin-clavulanic acid; pip-tazo: piperacillin tazobactam; SXT: sulfamethoxazole trimethoprim.
Data are presented as numbers (percentages).